| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,303 |
13,477 |
$512K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,606 |
7,220 |
$387K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,810 |
3,609 |
$219K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,777 |
8,634 |
$214K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,571 |
3,521 |
$174K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,048 |
1,033 |
$51K |
| 90832 |
Psychotherapy, 30 minutes with patient |
528 |
392 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
804 |
760 |
$29K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
266 |
263 |
$26K |
| 99215 |
Prolong outpt/office vis |
207 |
198 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
200 |
196 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
946 |
931 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
154 |
148 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
66 |
65 |
$8K |
| 99383 |
|
74 |
70 |
$7K |
| 99381 |
|
59 |
57 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
410 |
400 |
$5K |
| 96127 |
|
369 |
355 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
85 |
83 |
$4K |
| D1206 |
Topical application of fluoride varnish |
231 |
226 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
72 |
71 |
$3K |
| D0145 |
Oral evaluation for a patient under three years of age |
88 |
85 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
16 |
16 |
$2K |
| 0071A |
|
41 |
41 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
83 |
62 |
$2K |
| 99382 |
|
12 |
12 |
$1K |
| 99173 |
|
264 |
259 |
$947.38 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
26 |
25 |
$774.25 |
| 90686 |
|
2,250 |
2,218 |
$575.07 |
| 90474 |
|
38 |
38 |
$414.03 |
| 90480 |
|
12 |
12 |
$254.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17 |
17 |
$248.64 |
| 85018 |
|
99 |
98 |
$227.48 |
| 87807 |
|
15 |
14 |
$183.40 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
13 |
12 |
$133.92 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
27 |
$98.55 |
| 81002 |
|
27 |
26 |
$81.16 |
| 88720 |
|
12 |
12 |
$60.24 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14 |
13 |
$23.41 |
| 36416 |
|
36 |
28 |
$3.16 |
| 90461 |
|
3,654 |
3,615 |
$0.06 |
| 90656 |
|
495 |
491 |
$0.01 |
| 90670 |
|
1,195 |
1,176 |
$0.00 |
| 90633 |
|
404 |
397 |
$0.00 |
| 90710 |
|
28 |
28 |
$0.00 |
| 90681 |
|
95 |
95 |
$0.00 |
| 90723 |
|
1,143 |
1,129 |
$0.00 |
| 91307 |
|
112 |
103 |
$0.00 |
| 90647 |
|
983 |
972 |
$0.00 |
| 90680 |
|
403 |
399 |
$0.00 |
| 90677 |
|
637 |
633 |
$0.00 |
| 90716 |
|
13 |
13 |
$0.00 |